BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 26919854)

  • 1. Pre-therapeutic fibrinogen levels are of prognostic significance in locally advanced head and neck cancer.
    Selzer E; Grah A; Heiduschka G; Kornek G; Thurnher D
    Wien Klin Wochenschr; 2016 May; 128(9-10):320-8. PubMed ID: 26919854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen and Neutrophil-to-lymphocyte Ratio Predicts Survival in Patients with Advanced Hypopharyngeal Squamous Cell Carcinoma.
    Kuwahara T; Takahashi H; Sano D; Matsuoka M; Hyakusoku H; Hatano T; Hiiragi Y; Oridate N
    Anticancer Res; 2018 Sep; 38(9):5321-5330. PubMed ID: 30194184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of circulating biomarker score in advanced-stage head and neck squamous cell carcinoma.
    Park MJ; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
    Eur J Cancer; 2018 Mar; 92():69-76. PubMed ID: 29428866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary radiotherapy or postoperative radiotherapy in patients with head and neck cancer: Comparative analysis of inflammation-based prognostic scoring systems.
    Selzer E; Grah A; Heiduschka G; Kornek G; Thurnher D
    Strahlenther Onkol; 2015 Jun; 191(6):486-94. PubMed ID: 25583136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma.
    Ning ZH; Zhao W; Li XD; Chen LJ; Xu B; Gu WD; Shao YJ; Xu Y; Huang J; Pei HL; Jiang JT
    Int J Clin Exp Pathol; 2015; 8(6):6881-90. PubMed ID: 26261575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of VEGF and FLT-1 receptor expression in patients with locally advanced squamous cell carcinoma of the head and neck.
    Seibold ND; Schild SE; Bruchhage KL; Gebhard MP; Noack F; Rades D
    Strahlenther Onkol; 2013 Aug; 189(8):639-46. PubMed ID: 23748230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemoglobin and creatinine values as prognostic factors for outcome of concurrent radiochemotherapy in locally advanced head and neck cancers : Secondary results of two European randomized phase III trials (ARO 95-06, SAKK 10/94).
    Ghadjar P; Pöttgen C; Joos D; Hayoz S; Baumann M; Bodis S; Budach W; Studer G; Stromberger C; Zimmermann F; Kaul D; Plasswilm L; Olze H; Bernier J; Wust P; Aebersold DM; Budach V
    Strahlenther Onkol; 2016 Aug; 192(8):552-60. PubMed ID: 27323753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of EGFR as prognostic factor in head and neck cancer patients treated with surgery and postoperative radiotherapy: proposal of a new approach behind the EGFR overexpression.
    Alterio D; Marvaso G; Maffini F; Gandini S; Chiocca S; Ferrari A; Preda L; Rocca MC; Lepanto D; Fodor C; Volpe S; Dicuonzo S; Laudati A; Giugliano G; Ansarin M; Jereczek-Fossa BA
    Med Oncol; 2017 Jun; 34(6):107. PubMed ID: 28452036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the prognostic role of tumor cell podoplanin expression in locally advanced squamous cell carcinoma of the head and neck.
    Huttenlocher S; Seibold ND; Gebhard MP; Noack F; Thorns C; Hasselbacher K; Wollenberg B; Schild SE; Rades D
    Strahlenther Onkol; 2014 Oct; 190(11):1021-7. PubMed ID: 24928249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer.
    Rades D; Stoehr M; Meyners T; Bohlen G; Nadrowitz R; Dunst J; Schild SE; Wroblewski J; Albers D; Schmidt R; Alberti W; Tribius S
    Strahlenther Onkol; 2008 Apr; 184(4):198-205. PubMed ID: 18398584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of low hemoglobin levels on outcomes of radiotherapy following microscopically complete resection of locally advanced SCCHN: Implications for the future.
    Rades D; Seidl D; Janssen S; Wollenberg B; Hakim SG; Schild SE
    J Craniomaxillofac Surg; 2016 Sep; 44(9):1441-4. PubMed ID: 27470216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neutrophil to lymphocyte ratio in peripheral blood: a novel independent prognostic factor in patients with head and neck squamous cell carcinoma].
    Wu F; Wu LL; Zhu LX
    Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):29-32. PubMed ID: 28104030
    [No Abstract]   [Full Text] [Related]  

  • 13. Indications for postoperative radiotherapy in laryngeal carcinoma: a panel of tumor tissue markers for predicting locoregional recurrence in surgically treated carcinoma. A pilot study.
    Marioni G; Blandamura S; Lionello M; Giacomelli L; Lovato A; Favaretto N; Breda S; Tealdo G; Guzzardo V; Ottaviano G; Staffieri A
    Head Neck; 2014 Nov; 36(11):1534-40. PubMed ID: 23996283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in head-and-neck cancer patients treated with surgery followed by intensity-modulated radiotherapy (IMRT), 3D-conformal radiotherapy, or conventional radiotherapy.
    Rades D; Fehlauer F; Wroblesky J; Albers D; Schild SE; Schmidt R
    Oral Oncol; 2007 Jul; 43(6):535-43. PubMed ID: 17005437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can radiological changes in lymph node volume during treatment predict success of radiation therapy in patients with locally advanced head and neck squamous cell carcinoma?
    Mishra S; Hammond A; Read N; Venkatesan V; Winquist E; Nichols A; Warner A; Palma D
    J Med Imaging Radiat Oncol; 2013 Oct; 57(5):603-9. PubMed ID: 24119277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locally advanced stage IV squamous cell carcinoma of the head and neck: impact of pre-radiotherapy hemoglobin level and interruptions during radiotherapy.
    Rades D; Stoehr M; Kazic N; Hakim SG; Walz A; Schild SE; Dunst J
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1108-14. PubMed ID: 17905528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil-to-lymphocyte ratio: Prognostic indicator for head and neck squamous cell carcinoma.
    Rosculet N; Zhou XC; Ha P; Tang M; Levine MA; Neuner G; Califano J
    Head Neck; 2017 Apr; 39(4):662-667. PubMed ID: 28075517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Volumetric stratification of cT4 stage head and neck cancer.
    Studer G; Glanzmann C
    Strahlenther Onkol; 2013 Oct; 189(10):867-73. PubMed ID: 24002381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil-to-lymphocyte ratio in head and neck cancer.
    Haddad CR; Guo L; Clarke S; Guminski A; Back M; Eade T
    J Med Imaging Radiat Oncol; 2015 Aug; 59(4):514-519. PubMed ID: 25908427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensity-modulated versus 3-dimensional conformal radiotherapy in the definitive treatment of esophageal cancer: comparison of outcomes and acute toxicity.
    Haefner MF; Lang K; Verma V; Koerber SA; Uhlmann L; Debus J; Sterzing F
    Radiat Oncol; 2017 Aug; 12(1):131. PubMed ID: 28810885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.